An RNA-binding protein αCP-1 is involved in the STAT3-mediated suppression of NF-κB transcriptional activity

International Immunology

Volumn 19, Issue 5, 2007, Pages 609-619

  Nishinakamura, Hitomi ^a   Minoda, Yasumasa ^a   Saeki, Kazuko ^a   Koga, Keiko ^a   Takaesu, Giichi ^a   Onodera, Masafumi ^b   Yoshimura, Akihiko ^a   Kobayashi, Takashi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Gene regulation; IL 10; Lipopolysaccharide; NF B; Signal transduction; STAT3; Toll like receptor 4

Indexed keywords

DNA; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 16; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN ALPHACP 1; PYRIMIDINE; RNA BINDING PROTEIN; SMALL INTERFERING RNA; STAT3 PROTEIN; STAT3C PROTEIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; ENZYME ACTIVATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; RNA TRANSLATION; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; CARRIER PROTEINS; CLONING, MOLECULAR; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MICE; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 34249681852     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxm026     Document Type: Article

References (37)

1. Moore, K. W., de Waal Malefyt, R., Coffman, R. L. and O'Garra, A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683.
2. Lee, T S. and Chau, L. Y. 2002. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice, Nat. Med. 8:240.
3. Schottelius, A. J., Mayo, M. W., Sartor, R. B. and Baldwin, A. S. Jr 1999. Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J. Biol. Chem. 274:31868.
4. Bhattacharyya, S., Sen, P., Wallet, M., Long, B., Baldwin, A. S. Jr and Tisch, R. 2004. Immunoregulation of dendritic cells by IL-10 is mediated through suppression of the P13K/Akt pathway and of IkappaB kinase activity. Blood 104:1100.
5. Kuwata, H., Watanabe, Y., Miyoshi, H. et al. 2003. IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-alpha production in macrophages. Blood 102:4123.
6. Rajasingh, J., Bord, E., Luedemann, C. et al. 2006. IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression. FASEB J. 20:2112.
7. Takeda, K., Clausen, B. E., Kaisho, T. et al. 1999. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10:39.
8. Williams, L., Bradley, L., Smith, A. and Foxwell, B. 2004. Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J. Immunol. 172:567.
9. Yasukawa, H., Ohishi, M., Mori, H. et al. 2003. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat. Immunol. 4:551.
10. El Kasmi, K. C., Holst, J., Coffre, M. et al. 2006. General nature of the STAT3-activated anti-inflammatory response. J. Immunol. 177:7880.
11. Wang, T., Niu, G., Kortylewski, M. et al. 2004. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat. Med. 10:48.
12. Butcher, B. A., Kim, L., Panopoulos, A. D., Watowich, S. S., Murray, P. J. and Denkers, E. Y. 2005. IL-10-independent STAT3 activation by Toxoplasma gondii mediates suppression of IL-12 and TNF-alpha in host macrophages. J. Immunol. 174:3148.
13. Hanada, T., Tanaka, K., Matsumura, Y. et al. 2005. Induction of hyper Th1 cell-type immune responses by dendritic cells lacking the suppressor of cytokine signaling-1 gene. J. Immunol. 174:4325.
14. Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G. et al. 1999. Stat3 as an oncogene. Cell 98:295.
15. Nakajima, K., Yamanaka, Y., Nakae, K. et al. 1996. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J. 15:3651.
16. Suzuki, A., Obi, K., Urabe, T et al. 2002. Feasibility of ex vivo gene therapy for neurological disorders using the new retroviral vector GCDNsap packaged in the vesicular stomatitis virus G protein. J Neurochem. 82:953.
17. Kinjyo, I., Inoue, H., Hamano, S. et al. 2006. Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1. J. Exp. Med. 203:1021.
18. Morita, S., Kojima, T. and Kitamura, T. 2000. Plat-E: An efficient and stable system for transient packaging of retroviruses. Gene Ther. 7: 1063.
19. Fujita, T, Nolan, G. P., Liou, H. C., Scott, M. L. and Baltimore, D. 1993. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. Genes Dev. 7:1354.
20. Minoda, Y., Saeki, K., Aki, D. et al. 2006. A novel Zinc finger protein, ZCCHC11, interacts with TIFA and modulates TLR signaling. Biochem. Biophys. Res. Commun. 344:1023.
21. Kuwata, H., Matsumoto, M., Atarashi, K. et al. 2006. IkappaBNS inhibits induction of a subset of Toll-like receptor-dependent genes and limits inflammation. Immunity 24:41.
22. Mashima, R., Saeki, K., Aki, D. et al. 2005. FLN29, a novel interferon- and LPS-inducible gene acting as a negative regulator of toll-like receptor signaling. J. Biol. Chem. 280:41289.
23. Saeki, K., Miura, Y., Aki, D., Kurosaki, T. and Yoshimura, A. 2003. The B cell-specific major raft protein, Raftlin, is necessary for the integrity of lipid raft and BCR signal transduction. EMBO J. 22:3015.
24. Chinen, T., Kobayashi, T., Ogata, H. et al. 2006. Suppressor of cytokine signaling-1 regulates inflammatory bowel disease in which both IFNgamma and IL-4 are involved. Gastroenterology 130:373.
25. Aki, D., Mashima, R., Saeki, K., Minoda, Y., Yamauchi, M. and Yoshimura, A. 2005. Modulation of TLR signalling by the C-terminal Src kinase (Csk) in macrophages. Genes Cells 10:357.
26. Kinjyo, I., Hanada, T, Inagaki-Ohara, K. et al. 2002. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17:583.
27. Yuan, Z. L., Guan, Y. J., Chatterjee, D. and Chin, Y. E. 2005. Stat3 dimerization regulated by reversible acetylation of a single lysine residue. Science 307:269.
28. Paulding, W. R. and Czyzyk-Krzeska, M. F. 1999. Regulation of tyrosine hydroxylase mRNA stability by protein-binding, pyrimidine-rich sequence in the 3′-untranslated region. J. Biol. Chem. 274:2532.
29. Rivera-Gines, A., Cook, R. J., Loh, H. H. and Ko, J. L. 2006. Interplay of Sps and poly(C) binding protein 1 on the mu-opioid receptor gene expression. Biochem. Biophys. Res. Commun. 345:530.
30. Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. and Muller, W. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263.
31. Hirotani, T., Lee, P. Y., Kuwata, H. et al. 2005. The nuclear IkappaB protein IkappaBNS selectively inhibits lipopolysaccharide-induced IL-6 production in macrophages of the colonic lamina propria. J. Immunol. 174:3650.
32. Makeyev, A. V. and Liebhaber, S. A. 2002. The poly(C)-binding proteins: a multiplicity of functions and a search for mechanisms. RNA 8:265.
33. Makeyev, A. V., Chkheidze, A. N. and Liebhaber, S. A, 1999. A set of highly conserved RNA-binding proteins, alphaCP-1 and alphaCP-2, implicated in mRNA stabilization, are coexpressed from an intronless gene and its intron-containing paralog. J. Biol. Chem. 274:24849.
34. Mahtani, K. R., Brook, M., Dean, J. L., Sully, G., Saklatvala, J. and Clark, A. R. 2001. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol. Cell. Biol. 21:6461.
35. Collier, B., Goobar-Larsson, L., Sokolowski, M. and Schwartz, S. 1998. Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2. J. Biol. Chem. 273:22648.
36. Perrotti, D., Cesi, V., Trotta, R. et al. 2002. BCR-ABL suppresses C/ EBPalpha expression through inhibitory action of hnRNP E2. Nat. Genet. 30:48.
37. Ostareck, D. H., Ostareck-Lederer, A., Wilm, M., Thiele, B. J., Mann, M. and Hentze, M. W. 1997. mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3′ end. Cell 89:597.